DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer

Surgery

Volumn 139, Issue 3, 2006, Pages 279-282

  Machens, Andreas ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN RET;

CANCER SURGERY; CHEMICAL ANALYSIS; CODON; GENE MUTATION; GENETIC ALGORITHM; GENETIC ANALYSIS; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MARFAN SYNDROME; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SKELETON MALFORMATION; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR GROWTH;

ALGORITHMS; CARCINOMA, MEDULLARY; CODON; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; PATIENT SELECTION; PEDIGREE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 33645015594     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.07.034     Document Type: Review

References (12)

1. C. Eng Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease N Engl J Med 335 1996 943 951
2. A. Machens, J. Ukkat, M. Brauckhoff, O. Gimm, H. Dralle Advances in the management of hereditary thyroid cancer J Intern Med 257 2005 50 59
3. A. Machens, M. Brauckhoff, H.J. Holzhausen, P.N. Thanh, H. Lehnert, H. Dralle Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2 J Clin Endocrinol Metab 90 2005 3999 4003
4. A. Machens, Niccoli-Sire-P, J. Högel, K. Frank-Raue, T.J. van Vroonhoven, H.D. Roeher European Multiple Endocrine Neoplasia (EUROMEN) Study Group Early malignant progression of hereditary medullary thyroid cancer N Engl J Med 349 2003 1517 1525
5. B. Pasini, R. Rossi, M.R. Ambrosio, M.C. Zatelli, M. Gullo, M. Gobbo RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease Surgery 131 2002 373 381
6. A. Machens, U. Schneyer, H.J. Holzhausen, F. Raue, H. Dralle Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation Surgery 136 2004 1083 1087
7. H.J. Karga, M.K. Karayianni, D.A. Linos, S.C. Tseleni, K.D. Karaiskos, P.D. Papapetrou Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma Eur J Endocrinol 139 1998 410 415
8. M. Colombo-Benkmann, J. Brämswig, W. Höppner, R. Gellner, K. Hengst, W. Böcker Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia World J Surg 26 2002 1286 1290
9. M. Robledo, L. Gil, M. Pollán, A. Cebrián, S. Ruíz, M. Azanedo Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A Cancer Res 63 2003 1814 1817
10. O. Gimm, B.E. Niederle, T. Weber, M. Bockhorn, J. Ukkat, M. Brauckhoff RET proto-oncogene mutations affecting codon 790/791 a mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 132 2002 952 959
11. M.S. Rosenthal, H.H. Pierce Inherited medullary thyroid cancer and the duty to warn revisiting Pate v. Threkel in light of HIPPA Thyroid 15 2005 140 145
12. F. Carlomagno, T. Guida, S. Anaganti, G. Vecchio, A. Fusco, A.J. Ryan Disease associated mutations at valin 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors Oncogene 23 2004 6056 6063